Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.70
At close: Jun 13, 9:29 AM EDT
$1.84
0.148.24%
Pre-Market: Jun 13, 9:29 AM EDT
Comments
Loading...
SAB Biotherapeutics (SABS) Forecast
NewsEarningsSAB Biotherapeutics (SABS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
SAB Biotherapeutics Stock Price, Quotes and Forecasts | NASDAQ:SABS | Benzinga
Explore SAB Biotherapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SABS.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy SAB Biotherapeutics (SABS) stock?
You can purchase shares of SAB Biotherapeutics (NASDAQ:SABS) through any online brokerage.
Who are SAB Biotherapeutics (SABS) competitors?
Other companies in SAB Biotherapeutics’s space includes: Ernexa Therapeutics (NASDAQ:ERNA), HOOKIPA Pharma (NASDAQ:HOOK), Imunon (NASDAQ:IMNN), CARISMA Therapeutics (NASDAQ:CARM) and Cellectar Biosciences (NASDAQ:CLRB).
What is the forecast, or price target, for SAB Biotherapeutics (SABS) stock?
SAB Biotherapeutics has a consensus price target of $11.17.
What is the current price for SAB Biotherapeutics (SABS)?
The stock price for SAB Biotherapeutics (NASDAQ: SABS) is $1.84 last updated June 13, 2025 at 9:29 AM EDT.
Does SAB Biotherapeutics (SABS) pay a dividend?
There are no upcoming dividends for SAB Biotherapeutics.
When is SAB Biotherapeutics (NASDAQ:SABS) reporting earnings?
SAB Biotherapeutics’s Q2 earnings are confirmed for Thursday, August 7, 2025.
Is SAB Biotherapeutics (SABS) going to split?
There is no upcoming split for SAB Biotherapeutics.
What sector and industry does SAB Biotherapeutics (SABS) operate in?
SAB Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
